Osteoporosis medication adherence is poor

Share this article:
Adherence to osteoporosis medications is relatively poor, according to recent article in the journal Drugs & Aging. About 20% to 30% of patients taking daily or weekly treatments may suspend use within six to 12 months of initiating therapy, a study appearing in the January issue said.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.